Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Dec 27, 2023; 15(12): 2693-2708
Published online Dec 27, 2023. doi: 10.4240/wjgs.v15.i12.2693
Published online Dec 27, 2023. doi: 10.4240/wjgs.v15.i12.2693
Ref. | Country | Study type | Patients | Camera device | ICG dose and time | Approach | Target liver | Success rate | Median (range) operative time, in minutes |
Funamizu et al[21], 2021 | Japan | Retrospective cohort | 74 | Viscera Elite II, Olympus, Pinpoint, Stryker, Hopkins II, Karl storz | 0.5 mg | Glissonian pedicle approach | Monosegmectomy | 100% | 351 |
Xu et al[15], 2020 | China | Retrospective cohort | 27 | Pinpoint, Stryker | 2.5 mg/mL | Glissonian pedicle approach | Hemiliver. Section. Segment | 52% | 260 (150-360) |
Uchiyama et al[19], 2011 | Japan | Prospective cohort | 22 | PDE; Hamamatsu Photonic | 0.5 mg/kg | CE-IOUS: Glissonian pedicle approach | Hemiliver: 8. Section: 8. Segment: 6 | 100% | 280 (140-380) |
Berardi et al[20], 2021 | Japan | Retrospective cohort | 86 patients: HCC: 55; CRLM: 31 | Viscera Elite II, Olympus, Pinpoint, Stryker, Hopkins II, Karl storz | 0.5 mg | Glissonian approach | Section: 14. Segment: 56. Sub-segment: 16 | 98.80% | 328 (270-437) |
- Citation: Kalayarasan R, Chandrasekar M, Sai Krishna P, Shanmugam D. Indocyanine green fluorescence in gastrointestinal surgery: Appraisal of current evidence. World J Gastrointest Surg 2023; 15(12): 2693-2708
- URL: https://www.wjgnet.com/1948-9366/full/v15/i12/2693.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i12.2693